Skip to content

Decompressive Hemicraniectomy in Malignant Middle Cerebral Artery Infarction: a Randomized Controlled Trail Enrolling a Group of Patients Older than 60 Years of Age

Decompressive Hemicraniectomy in Malignant Middle Cerebral Artery Infarction: a Randomized Controlled Trail Enrolling a Group of Patients Older than 60 Years of Age

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001757
Enrollment
Unknown
Registered
2011-12-01
Start date
2008-08-04
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant middle cerebral artery (MCA) infarction (massive hemispheric cerebral infarction)

Interventions

Surgical Group:Decompressive hemicraniotomy plus standard medical treatment
Medical Group:standard medical treatment

Sponsors

Xuanwu Hospital of the Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) age between 18 and 80 years old; (2) inclusion within 43 hours of stroke onset; (3) able to start surgery within 5 hours after randomization; (4) decrease in consciousness to an eye and motor score of <=9 on the Glasgow coma scale (GCS); (5) ischemic signs on subsequent cerebral computed tomography (CCT) involving at least 2/3 of the MCA territory with or without additional infarction in the territory of the anterior or posterior cerebral artery (ACA/PCA) on the same side and the development of space-occupying edema (e.g., compression of the ipsilateral ventricle or displacement of midline structures); (6) written, informed consent given by the closest ralatives of patients.

Exclusion criteria

Exclusion criteria: (1) prestroke score on the modified Rankin Scale (mRS)>2; (2) diminished consciousness due to other causes such as metabolic disturbances or medication, rather than to the formation of space-occupying edema; (3) a GCS score without the verbal response item <6; (4) a dilated and fixed pupil ipsilateral to the infarct side; (5) a concomitant contralateral infarction or a secondary space-occupying hemorrhage in the area of infarction; (6) any other coincidental brain lesion or serious illness that might affect outcome; (7) life expectancy less than 3 year; (8) contraindications for anaesthesia or surgery, including known coagulopathy, systemic bleeding disorder, or pregnancy, etc..

Design outcomes

Primary

MeasureTime frame
the modified Rankin Scale (mRS);

Secondary

MeasureTime frame
Mortality;

Countries

China

Contacts

Public ContactYingying Su
suyingying28@yahoo.com.cn+86 15699959572

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 25, 2026